DRUG FORM FOR DELIVERY OF MEDICATION INTO LARGE INTESTINE Russian patent published in 2013 - IPC A61K9/28 A61K9/22 A61K31/606 A61K47/30 A61K47/36 A61P1/00 A61P29/00 A61P35/00 A61J3/00 

Abstract RU 2478372 C2

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention relates to drug form with delayed release for delivery of medication into large intestine. Drug form includes part with core and core coating, where core includes medication and coating. Coating includes mixture of sensitive to influence of large intestine bacteria substance and film-forming polymeric substance, which is not soluble at Ph lower than 5 and soluble at pH higher than 5. As sensitive to influence of large intestine bacteria substance used is starch, containing not more than 75% of amilose. Invention also relates to method of obtaining said drug form, which lies in formation of core and covering core with covering composition, which includes mixture of starch, which contains not more than 75% of amilose, and film-forming polymeric substance.

EFFECT: invention relates to application of claimed drug form for production of medication for treatment of inflammatory disease of intestine and carcinoma, as well as to methods of treating said diseases by introduction of therapeutically efficient amount of claimed drug form.

28 cl, 17 dwg, 1 tbl, 5 ex

Similar patents RU2478372C2

Title Year Author Number
PHARMACEUTICAL FORM FOR DRUG DELIVERY TO THE COLON 2007
  • Basit Abdul Vasekh
  • Ibekve Valentine Chidi
RU2646825C2
COATING COMPOSITION CONTAINING STARCH 2007
  • Podzhek Gizela Fridran
  • Frejri Ana Kristina Teshejra Di Almejda Lopes
RU2440104C2
COMPOSITION EXHIBITING THE DELAYED (PROLONGED) RELEASING 1990
  • Stiven Gordon Ring[Gb]
  • Dehvid Brajan Archer[Gb]
  • Majkl Charl'Z Ollvud[Gb]
  • Dzhon Majkl N'Juton[Gb]
RU2093148C1
COMPOSITION WITH CONTROLLED RELEASE 2003
  • Spirz Kristofer Dzh.
  • Mojr Piter
  • Uill'Jams Richard
  • Klark Majkl
RU2336865C2
FORMULATIONS FOR ORAL DELIVERY OF ADSORBENTS IN INTESTINE 2016
  • Lescure, Francois
  • De Gunzburg, Jean
RU2681315C2
MEDICINAL CONTROLLED-RELEASING FORMS OF AZITHROMYCIN 1995
  • Uill'Jam Dzh.Kuratolo
  • Khilar L.Fridman
  • Richard V.Korsmejer
  • Stiven R.Le Mott
RU2130311C1
PHARMACEUTICAL MEDICINAL FORM, RESISTANT TO GASTRIC JUICE ACTIVITY, WHICH INCLUDES N-(2-(2-PHTHALIMIDOETOXY)ACETYL)-L-ALANYL-D-GLUTAMIC ACID (LK 423) 2005
  • Bogataj Marija
  • Mrkhar Ales
  • Lavrits Anton
  • Tserne Manitsa
  • Tibaut Doris
  • Stalts Anton
  • Urleb Uros
  • Mateovits Tat'Jana
  • Tsof Greta
  • Kerk Janez
  • Dreu Rok
  • Joneda Fumio
  • Muraoka Shizuko
RU2375047C2
MEDICINAL FORMS ON BASIS OF BIPHOSPHONATES 2005
  • Dansero Richard Dzhon
  • Berdzhio Dehvid Ehrnest Ml.
RU2359678C2
CHOLESTYRAMINE PELLETS, ORAL CHOLESTYRAMINE COMPOSITIONS AND THEIR USE 2018
  • Jillberg, Per-Jeran
  • Gustafsson, Nils Ove
  • Levgren, Kurt
RU2782016C2
CROSS-LINKED HIGH-AMYLOSE STARCH FOR USING IN PHARMACEUTICAL COMPOSITION WITH SUSTAINED-RELEASING AND METHOD FOR ITS PREPARING 2001
  • Lenarts Vinsent
  • Bek Roland Khervig Fridrikh
  • Bogart Ehlsi Van
  • Shuinar Fransua
  • Khopke Rajner
  • Dezevo Siril
RU2274443C2

RU 2 478 372 C2

Authors

Basit Abdul Vasekh

Ibekve Valentine Chidi

Dates

2013-04-10Published

2007-04-13Filed